Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disturbed natural killer cell homeostasis in the salivary gland enhances autoimmune pathology via IFN-γ in a mouse model of primary Sjögren's syndrome.
Sato M, Arakaki R, Tawara H, Nagao R, Tanaka H, Tamura K, Kawahito Y, Otsuka K, Ushio A, Tsunematsu T, Ishimaru N. Sato M, et al. Among authors: tanaka h. Front Med (Lausanne). 2022 Oct 26;9:1036787. doi: 10.3389/fmed.2022.1036787. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36388880 Free PMC article.
KRAS Mutations in Duodenal Lavage Fluid after Secretin Stimulation for Detection of Pancreatic Cancer.
Yachida S, Yoshinaga S, Shiba S, Urabe M, Tanaka H, Takeda Y, Shimizu A, Sakamoto Y, Hijioka S, Haba S, Ashida R, Kushiyama Y, Asano K, Kobayashi M, Murawaki Y, Onishi K, Yamashita T, Kimura H, Totoki Y, Kamada H, Isomoto H, Hattori S, Morizane C, Ohkawa K, Kitano M, Hara K, Ikezawa K, Hanada K, Matsumoto K. Yachida S, et al. Among authors: tanaka h. Ann Surg. 2025 Feb 4. doi: 10.1097/SLA.0000000000006645. Online ahead of print. Ann Surg. 2025. PMID: 39902566
The current status of tumor markers as biomarkers in the era of immunotherapy for hepatocellular carcinoma: alpha-fetoprotein alone is not sufficient.
Hiraoka A, Kudo M, Tada T, Hatanaka T, Kakizaki S, Kariyama K, Ohama H, Tsuji K, Ishikawa T, Takaguchi K, Itobayashi E, Toyoda H, Matono T, Yata Y, Ogawa C, Naganuma A, Tani J, Atsukawa M, Nishimura T, Tajiri K, Kawata K, Kosaka H, Kuroda H, Hirooka M, Nishikawa H, Tada F, Nakamura S, Kanayama Y, Nouso K, Tanaka H, Tanaka K, Imai M, Tsutsui A, Nagano T, Aoki T, Koshiyama Y, Morishita A, Itokawa N, Okubo T, Arai T, Fukunishi S, Noritake H, Nakamura Y, Yoshida O, Enomoto H, Kaibori M, Hiasa Y, Kumada T. Hiraoka A, et al. Among authors: tanaka h. Oncology. 2025 Feb 3:1-23. doi: 10.1159/000543405. Online ahead of print. Oncology. 2025. PMID: 39900019
Comparison of lifetime attributable risk of post-irradiation secondary cancer of boron neutron capture therapy, proton beam therapy, and X-ray therapy for pediatric and adolescent and young adult patients.
Suzuki S, Shiba S, Tanaka H, Yamanaka M, Matsumoto K, Tokuuye K, Omura M. Suzuki S, et al. Among authors: tanaka h. Clin Transl Radiat Oncol. 2025 Jan 12;51:100921. doi: 10.1016/j.ctro.2025.100921. eCollection 2025 Mar. Clin Transl Radiat Oncol. 2025. PMID: 39898334 Free PMC article.
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial.
Lee KH, Lee JS, Sugawara S, Kang JH, Kim HR, Inui N, Hida T, Yoshida T, Tanaka H, Yang CT, Inoue T, Nishio M, Ohe Y, Tamura T, Yamamoto N, Yu CJ, Akamatsu H, Takahashi S, Nakagawa K. Lee KH, et al. Among authors: tanaka h. Lung Cancer. 2025 Jan 25;201:108109. doi: 10.1016/j.lungcan.2025.108109. Online ahead of print. Lung Cancer. 2025. PMID: 39893774 Free article.
Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.
Kikuchi H, Osawa T, Matsushita Y, Kojima T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Ueda K, Tanaka H, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Kato T, Hara H, Ito Y, Kitamura H, Miyake H, Shinohara N. Kikuchi H, et al. Among authors: tanaka h. Jpn J Clin Oncol. 2025 Feb 2:hyaf018. doi: 10.1093/jjco/hyaf018. Online ahead of print. Jpn J Clin Oncol. 2025. PMID: 39893579
15,427 results
You have reached the last available page of results. Please see the User Guide for more information.